BCL2 and ovarian cancer: Regarding the PI3K/AKT/mTOR pathway, which is typically overactivated in ovarian cancer (Mabuchi et al., 2015), it represents a regulatory mechanism controlling the activity of pro- and anti-apoptotic Bcl-2 family proteins.